Clinical Trial Update: ABF Tourette's Disorder Post Marketing Surveillance Study

View source ↗

Summary

Post-marketing surveillance study on ABF for Tourette's Disorder has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome

Drugs mentioned

• ABF

Snippet

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Tourette's Disorder | Status: COMPLETED | Results posted: 2019-04-01